Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 23, 2024 06:30 ET | Source: XOMA Corporation

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA(TM) becomes 6th commercial asset in XOMA Royalty's portfolio
January 06, 2020 08:00 ET | Source: ORPHAZYME A/S

Orphazyme announces US Early Access Program for Niemann-Pick disease Type C

Orphazyme A/SCompany announcement No....